Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
526-540 of 2993 results
Biocept secures agreements with Stratose and Galaxy Health Network for its blood-based oncology diagnostic assays
By MDBR Staff Writer
Biocept, a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces additional agreements with preferred provider organizations (PPOs).
Diagnostics > In Vitro Diagnostics > News
Pathway Genomics launches liquid biopsy test to detect cancer-associated mutations in high-risk patients
By MDBR Staff Writer
Pathway Genomics, a global precision medical diagnostics company, announced the launch of CancerIntercept, its first liquid biopsy, a non-invasive screening test designed for early cancer detection and monitoring, for as low as $299.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific obtains IVDD CE mark approval for three new products
By MDBR Staff Writer
Thermo Fisher Scientific has obtained in vitro diagnostics device (IVDD) CE mark approval for its Prelude MD HPLC, Endura MD mass spectrometer and ClinQuan MD software.
Diagnostics > In Vitro Diagnostics > News
Meridian’s Bioline introduces new EPIK miRNA Panel Assays
By MDBR Staff Writer
Meridian Bioscience's wholly-owned subsidiary Bioline has introduced new EPIK miRNA Panel Assays across the globe.
Diagnostics > In Vitro Diagnostics > News
Focus obtains FDA approval to add genital swab claim to Simplexa HSV 1 & 2 Direct test
By MDBR Staff Writer
Focus Diagnostics, a subsidiary of Quest Diagnostics, has obtained 510(k) approval from the US Food and Drug Administration (FDA) to add the genital swab claim to its Simplexa HSV 1 & 2 Direct molecular test on the integrated cycler.
Diagnostics > In Vitro Diagnostics > News
Binding Site introduces special protein analyzer Optilite in North America
By MDBR Staff Writer
Special protein diagnostics provider Binding Site has introduced its fully-automated special protein analyzer Optilite in North America.
Diagnostics > In Vitro Diagnostics > News
NOWDiagnostics acquires Canada's ZBx
By MDBR Staff Writer
NOWDiagnostics recently completed its acquisition of ZBx Corporation of Canada, a move that brings the company closer to its vision of a world where people have greater access to information concerning their health.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific introduces two new NGS systems
By MDBR Staff Writer
Thermo Fisher Scientific has launched two new next-generation sequencing (NGS) systems, which provide comprehensive solution to simplify targeted sequencing.
Diagnostics > In Vitro Diagnostics > News
Transgenomic selects distributors to supply ICEme Mutation Enrichment Kits in China and Japan
By MDBR Staff Writer
Transgenomic has selected two distributors to supply its ICEme Mutation Enrichment Kits in China and Japan.
Diagnostics > In Vitro Diagnostics > News
Anteo Diagnostics to buy DIAsource ImmunoAssays
By MDBR Staff Writer
Australia's Anteo Diagnostics has agreed to acquire Belgium-based specialty diagnostics firm DIAsource ImmunoAssays, for around €15.4m (A$23.3m).
Diagnostics > In Vitro Diagnostics > News
Luminex seeks FDA approval for NxTAG Respiratory Pathogen Panel
By MDBR Staff Writer
Luminex is seeking approval from the US Food and Drug Administration (FDA) for its NxTAG Respiratory Pathogen Panel.
Diagnostics > In Vitro Diagnostics > News
Agena Bioscience introduces front-end automation for its MassARRAY System for genetic analysis
By MDBR Staff Writer
Agena Bioscience introduced the Chip prep module to automate sample handling after PCR for the MassARRAY 96-well System.
Diagnostics > In Vitro Diagnostics > News
Roche buys Lumora’s nucleic acid purification technology
By MDBR Staff Writer
Switzerland-based Roche has entered into an asset purchase agreement with Lumora for nucleic acid purification technology, in a bid to enhance its expertise in sample preparation for sequencing.
Diagnostics > In Vitro Diagnostics > News
Burning Rock, Illumina to develop molecular diagnostics for oncology
By MDBR Staff Writer
China-based diagnostics firm Burning Rock has partnered with Illumina, to develop advanced clinical applications for molecular diagnostics in oncology.
Diagnostics > In Vitro Diagnostics > News
Veritas’ myBRCA breast and ovarian cancer genetic screening test receives CE mark approval
By MDBR Staff Writer
US-based Veritas Genetics has obtained CE mark approval for its hereditary breast and ovarian cancer genetic screening test, myBRCA.
Diagnostics > In Vitro Diagnostics > News
526-540 of 2993 results